RR
Insider
Robin Shane Readnour
DirectorRobin Shane Readnour (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AN2 Therapeutics, Inc. (ANTX). The largest single filing was $213K of ANTX (35,402 sh across 2 lots, as filed), executed Aug 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$213K
shares × price, as filed
Last traded
Aug 17
Filed Aug 19
Median ADV $1.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $213K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ANTXRecent filings
ANTXSALE
AN2 Therapeutics, Inc.
View filing →
$213K35,402 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 5:58 PM ET